Obsidian Therapeutics IPO

Obsidian Therapeutics is a clinical-stage biotechnology specializing in engineered cell and gene therapies with a mission to deliver transformative outcomes for patients with intractable diseases. The company utilizes drug-responsive domains for controlled protein function in therapeutics, aiming for targeted treatment solutions. Obsidian Therapeutics was founded by Michael Gilman, Steve Shamah, and Tariq Kassum in 2015 and is headquartered in Cambridge, MA.

Register for Details

For more details on financing and valuation for Obsidian Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Obsidian Therapeutics

Forge green plus iconForge green minus icon

What is Obsidian Therapeutics's IPO price?

The IPO price for Obsidian Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Obsidian Therapeutics?

Obsidian Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Obsidian Therapeutics shares pre-IPO?

If you own Obsidian Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Obsidian Therapeutics a publicly traded company?

Obsidian Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Obsidian Therapeutics founded?

Obsidian Therapeutics was founded in 2015.

Who are Obsidian Therapeutics's major investors?

Wellington Management
Atlas Venture
Ra Capital Management
Takeda Ventures
Bristol Myers Squibb
Foresite Capital
Woodline Partners
Novo Holdings
Janus Henderson Investors
Amgen Ventures
Logos Capital
Samsara Biocapital
Soleus Capital
RTW Investments
Deep Track Capital
Blue Owl Capital
TCG Crossover Management
Johnson & Johnson Innovation
Surveyor Capital
Vertex Ventures HC
Revelation Partners
Cowen Healthcare Investments
Pivotal Life Sciences
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.